ALLISON KYLE: Open Payments
NPI 1679997753 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,287 in 56 payments from 14 companies in 2025. Trend: 2023 $917 · 2024 $1,269 · 2025 $1,287
Food & beverage: $1,192Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $209 |
| ABBVIE INC. | 9 | $207 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $161 |
| Novartis Pharmaceuticals Corporation | 9 | $160 |
| GENZYME CORPORATION | 3 | $94 |
| Regeneron Healthcare Solutions, Inc. | 3 | $86 |
| Amgen Inc. | 4 | $72 |
| Krystal Biotech Inc | 3 | $71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $52 |
| Almirall LLC | 2 | $51 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, COSENTYX, Odomzo, OTEZLA, VYJUVEK, ILUMYA.
Industry payments across FL — which companies pay providers there.
